Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/03/25
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 07/30/21
End: 12/30/24
Due: 12/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease | NCT06874621 | Voyager Therapeutics | user2@example.com | None | 2025-03-03 | 2027-05-31 | 2028-05-31 | - | - | 2025-07-14 |
| Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington's Disease | NCT04885114 | Voyager Therapeutics | user2@example.com | None | 2021-07-30 | 2024-12-30 | 2025-12-30 | - | - | 2025-07-14 |